Federal Trade Commission v. U.S. Anesthesia Partners, Inc. et al
Case Number:
4:23-cv-03560
Court:
Nature of Suit:
Judge:
Firms
- Beck Redden
- Cravath Swaine
- DLA Piper
- Gibson Dunn
- Hogan Lovells
- Kellogg Hansen
- Norton Rose
- Ropes & Gray
- Yetter Coleman
Companies
Government Agencies
Sectors & Industries:
-
July 09, 2024
Healthcare Cases To Watch: A 2024 Midyear Report
Courts across the U.S. this year will oversee key cases to the healthcare industry, from multidistrict litigation over the Change Healthcare hack to a challenge of a state gender-affirming care ban at the Supreme Court. Here are the healthcare cases to watch in the second half of 2024.
-
July 08, 2024
Texas Anesthesia Co. Can't Pause Or Appeal Suit, FTC Says
The Federal Trade Commission urged a Texas federal court not to pause its suit accusing U.S. Anesthesia Partners Inc. of a monopolistic "roll-up" of Lone Star State anesthesia practices, arguing the company can't appeal an order refusing to toss the case against it.
-
June 12, 2024
Texas Anesthesia Co. Appealing To Duck FTC Suit To 5th Circ.
U.S. Anesthesia Partners Inc. gave notice Wednesday that it will ask the Fifth Circuit to review a Texas federal judge's mid-May decision refusing to toss Federal Trade Commission allegations of a monopolistic "roll-up" of Lone Star State anesthesia practices.
-
May 28, 2024
Anesthesia 'Rollup' Decision May Hurry PE Regulator Suits
A recent Texas court ruling in a Federal Trade Commission case focused on an anesthesiology practice'sĀ alleged "rollup" strategy could spur regulators to move faster against private equity owners of healthcare businesses.
-
May 14, 2024
FTC Cleared To Sue Texas Anesthesia Co., But Not PE Firm
A Texas federal judge highlighted the limits of the Federal Trade Commission's ability to go after private equity firms accused of anti-competitive "roll-up" strategies, tossing antitrust claims against a private equity firm while preserving monopolization allegations against the anesthesia group the firm created.
-
April 08, 2024
PE Firm Calls FTC's Antitrust Claims 'Many Yesterdays' Old
A Texas anesthesiology company and the private equity firm that created it told a Houston federal judge Monday that the Federal Trade Commission has gone back "many yesterdays ago" in making its antitrust case, arguing that there's no imminent threat of a monopoly in an attempt to get the case dismissed.
-
January 22, 2024
FTC Fights Bids To Toss Texas Anesthesia Roll-Up Case
The Federal Trade Commission urged a Texas federal court not to toss the agency's antitrust case against Welsh Carson Anderson & Stowe and U.S. Anesthesia Partners, saying the private equity firm orchestrated a "roll up" strategy to create a dominant anesthesiology practice.
-
November 28, 2023
Sens. Question Anesthesia Co.'s 'Monopolistic' Model
Sens. Elizabeth Warren and Richard Blumenthal have asked the CEO of U.S. Anesthesia Partners to rethink its "monopolistic business model" and its use of noncompete agreements among doctors.
-
November 21, 2023
PE Firm, Anesthesia Practice Ask To Toss FTC Antitrust Case
Private equity firm Welsh Carson Anderson & Stowe and U.S. Anesthesia Partners Inc. have urged a Texas federal court to toss the Federal Trade Commission's antitrust case against them, arguing that a series of acquisitions helped improve patient care.
-
September 21, 2023
FTC Accuses PE Firm Of Raising Anesthesia Prices In Texas
The Federal Trade Commission lodged a lawsuit Thursday accusing private equity firm Welsh Carson Anderson & Stowe of buying up Texas anesthesiology practices and cutting deals with competitors in order to increase prices and boost its own profits.